Current view of treatment of hypoglycemia.
Současný pohled na léčbu hypoglykemie.
glucagon
glucose
hypoglycemia
therapy
type 1 diabetes
type 2 diabetes
Journal
Vnitrni lekarstvi
ISSN: 0042-773X
Titre abrégé: Vnitr Lek
Pays: Czech Republic
ID NLM: 0413602
Informations de publication
Date de publication:
2019
2019
Historique:
entrez:
17
5
2019
pubmed:
17
5
2019
medline:
23
8
2019
Statut:
ppublish
Résumé
Hypoglycemia is a side effect of the therapy primarily with insulin, sulphonylurea derivates and glinides. Its therapy is based on the immediate ingestion of sacharides, preferably glucose. Amount of 15-20 g is recommended as its optimal dose, although several recent studies are suggesting amount related to the patient´s weight. The therapy of severe hypoglycemia in the non-professional settings is based on glucagon injection, in the professional ones intravenous administration of glucose is preferable option.
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Insulin
0
Glucagon
9007-92-5
Types de publication
Journal Article
Langues
eng